The global stoma/ostomy care market holds a valuation of US$ 3.8 Billion by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 4.9%, and is expected to hold a market value of around US$ 6.5 Billion in 2033.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 3.8 Billion |
| Market Value 2023 | US$ 4.0 Billion |
| Market Value 2033 | US$ 6.5 Billion |
| CAGR 2023 to 2033 | 4.9% |
| Market Share of Top 5 Countries | 51.7% |
| Key Market Players | Coloplast Corp, BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc., 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc., Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG, Salts Healthcare Ltd., Securi–T USA, Welland Medical Limited and Flexicare Group Limited |
An ostomy device is a piece of artificial gastrointestinal medical device that makes a stoma by collecting waste from a biological system that has been surgically diverted (the colon, ileum, or bladder). An ostomy may be required due to congenital disability, bladder cancer, inflammatory bowel disease, diverticulitis, obesity, and other medical issues. Colostomy, urostomy, and ileostomy are the three main categories.
According to the Centers for Disease Control and Prevention (CDC), IBD (Inflammatory Bowel Disease), also known as Crohn's disease or ulcerative colitis, affects over 3 million (1.3%) individuals in the United States every year. The global market is expected to grow as inflammatory bowel disease becomes more prevalent globally.
The stoma or ostomy care business is expanding, due to advancements in ostomy devices, contributions by manufacturing companies to new technologies and growing patient education campaigns about the use of ostomy devices are the factors propelling the market ahead to grow further.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The stoma/ostomy care market expanded at a CAGR of 5.0% for 2017 to 2022 period.
The global market for stoma/ostomy care contributes around 37.8% to the global gastrointestinal devices market, valued at about US$ 10.05 Billion in 2022.
Increasing prevalence of Inflammatory bowel disease (IBD), colorectal cancer, public awareness of ostomy/stoma care, the availability of treatment options, as well as the established reimbursement policies funded by private and governmental organisations, are the main factors driving the stoma/ostomy care industry.
The market is also being driven by technological developments in the area of ostomy care products like the development of effective and well-designed pouching facility and related accessories that serve to enhance the quality of life for ostomy patients.
For instance, Trio Healthcare has launched Trio Siltac in 2016, an ostomy seal made of silicone. This item shields the skin surrounding the stoma and aids in preventing leakage. Over the forecast period, these developments are anticipated to accelerate market expansion.
The industry is expanding as a result of an increase in campaigns to educate people about ostomies. The United Ostomy Association of America Inc. (UOAA) stated that in October 2021, the UOAA was striving to raise the bar for care in all healthcare settings and to enhance the standard of ostomy healthcare in the USA
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 3.43% |
| Jul to Dec (H2), 2021 (A) | 4.26% |
| Jan to Jun (H1),2022 Projected (P) | 3.39% |
| Jan to Jun (H1),2022 Outlook (O) | 3.69% |
| Jul to Dec (H2), 2022 Outlook (O) | 4.59% |
| Jul to Dec (H2), 2022 Projected (P) | 4.32% |
| Jan to Jun (H1), 2023 Projected (P) | 3.51% |
| BPS Change : H1,2022 (O) – H1,2022 (P) | 30↑ |
| BPS Change : H1,2022 (O) – H1,2021 (A) | 26↑ |
| BPS Change: H2, 2022 (O) – H2, 2022 (P) | 27↑ |
| BPS Change: H2, 2022 (O) – H2, 2022 (A) | 34↑ |
Principal Consultant
The market for ostomy care products is highly driven by the increasing prevalence of patient pool suffering from cancers including colon and rectum cancer. This is increasing demand for various ostomy care products especially for the bedridden patients. Companies have been manufacturing products with human-centric design - comfortable, light, leak-free, and gently fits and moves with the patient's body as they bend. Hence, preferred by both patients and healthcare professionals.
ConvaTec Inc.'s Esteem+ Flex Convex product, for example, has a hydrocolloid skin barrier, stays firm with minimal leakage, and resists snagging on clothing.
The availability of numerous e-commerce sites selling surgical procedure-related products may increase sales of stoma care products. Some popular e-commerce sites such as Express Medical Supply Inc. and Amazon-Stoma bags that provide discounts, warranties, and prompt customer service on a variety of stoma care accessories. All of these factors are expected to provide a much-needed boost to the stoma/ostomy care sector.
Poor economic conditions in developing countries, a lack of reimbursement for ostomy care bags, a postoperative surgical complication, elevated risks involved with ostomy surgeries, anaesthesia reaction, bleeding, blood clots, septicaemia, wound infection, and unpleasant psychological and emotional effects of the ostomy or stoma surgery are all expected to hinder the stoma or ostomy care market.
The primary issue limiting the stoma care and accessories industry is ineffective and insufficient ostomy care accessory payment rules. Patients frequently obtain unnecessary National Health Service goods, resulting in billing or incorrect charging. The estimated incorrect billing amount for ostomy products in the USA for the year 2020 is US$ 93.4 million, according to the Medicare Learning Network. As a result of the troubling reimbursement procedures, concerns about inappropriate stoma care supply invoicing, are expected to impede the stoma or ostomy care market.
Although stomas are a relatively common and safe surgery, there are some risks. For example, skin irritation from ostomy appliance adhesive, risk of dehydration from waste exiting the stoma, leakage due to improper fitting, bowel obstruction due to improper food chewing or digestion, parastomal hernia, or necrosis. Most stoma complications are minor, but necrosis and dehydration can become medical emergencies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The USA |
|---|---|
| Market Share (2023) | 28.7% |
| Market Share (2033) | 26.4% |
| BPS Analysis | -227 |
| Country | Indonesia |
|---|---|
| Market Share (2023) | 7.2% |
| Market Share (2033) | 7.2% |
| BPS Analysis | 6 |
| Country | Russia |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 6.8% |
| BPS Analysis | 127 |
| Country | Germany |
|---|---|
| Market Share (2023) | 5.3% |
| Market Share (2033) | 4.7% |
| BPS Analysis | -60 |
| Country | Spain |
|---|---|
| Market Share (2023) | 5.0% |
| Market Share (2033) | 5.2% |
| BPS Analysis | 18 |
The USA market will hold the market share of around 28.7% in 2023 global market.
The USA currently is the largest shareholder in the global market. This may be attributed to a rising prevalence of IBD and increased awareness among population regarding ostomy care or stoma procedures. In addition, the ageing population anticipates an increase in the prevalence of IBD, colon, and bladder malignancies in the future.
According to the American Cancer Society, about 106,180 and 44,850 new cases of colorectal cancer and rectal cancer were reported in the USA for the year 2021.
According to Crohn’s and Colitis Foundation of America, around one in 500 Americans requires an ostomy drainage bag. 30% of those with U.C. will ultimately require ostomy bags, whether they are needed temporarily or permanently.
The Germany is set to hold around 5.3% of global market share in stoma/ostomy care in 2023.
According to GLOBOCAN statistics, colorectal cancer (CRC) is the fourth most common type of cancer among the German population, at about 57,528 new cases reported in Germany in 2021. Germany dominates market growth due to the high prevalence of Inflammatory Bowel Diseases (IBD), such as ulcerative colitis and Crohn's disease, which results in an increase in ostomy surgery cases.
A larger patient pool, as well as a better reimbursement structure and private insurance policies, all contribute to the growth in German market. Other factors driving this region’s growth includes an ageing population, an increase in cases of intestinal disorders, and increased investment in research and development, improved diagnostic technologies for chronic diseases, and the availability of products at an affordable price.
The Indian market is projected to expand at a CAGR of 3.8% during the forecast period.
Colorectal cancer is becoming more common in India. The risk increases with age, most cases being diagnosed in adults aged 65 to 74 years. As per Globocan 2018 data, there were 1,157,294 cancer cases and 784821 cancer deaths reported in 2018. Colorectal cancer occurred at a rate of 4.9% in India in 2018, with a death rate of 5.5%. In 2018, the incidence of stomach cancer was 5.0%, with a death rate of 6.6%.
Several nursing centres in this region offer a variety of initiatives to raise awareness among ostomy patients, including motivational programmes and instructional lectures. For example, India is a member of the Asia and South Pacific Ostomy Association (ASPOA) and helps to organise World Ostomy Day in India every year to improve ostomy rehabilitation by bringing their goals and needs to the general public and Indian community's attention. Additionally, a number of market players are trying to improve distribution networks in this region to take advantage of their growth prospects.
Ostomy Bags is expected to hold a significant revenue share of 84.3% in the global market by 2023, owing to an increasing number of patients suffering from target diseases such as colorectal cancer.
Crohn's disease, ulcerative colitis, and IBD symptoms can be extremely difficult at times, causing physical challenges as well as emotional distress. Considering patient’s ease, companies have developed ostomy bags which are ready to throw away once they are about three-quarters full, waterproof, leak-proof, odour-free and with lightly scented, closed bags are easy to change quickly at night or while travelling, and come in three sizes, small, midi (medium)
The colostomy segment is expected to hold significant market share of 88.8% within the global market in 2023 owing to the increased prevalence of IBD, bowel cancer, and colon cancer in both developed and developing countries, as well as the favourable reimbursement environment in developed countries.
Colostomy also aids in medical conditions where the colon or anus must be temporarily stopped in order to heal the gastrointestinal tract. After the patient has fully recovered from the first surgery, another surgery will be performed to reattach the ends of the large intestine. A colostomy procedure could be a long-term solution to an irreversible condition.
Cancer segment is anticipated to hold a market share around 58.0% in 2023 global market.
According to a 2019 article published in Prezeglad Gatroenterologiczny Journal on the epidemiology of gastric cancer, based on GLOBOCAN 2018 data, stomach cancer is the fifth most common cancer, contributing for 5.7% more new cases, and the third deadliest cancer, accounting for an estimated 783,000 deaths in 2018.
The home care settings segment is expected to hold a market share around 67.2% in 2023 globally.
Home Settings include large and small home health care, adult day-care centers and assisted living facilities. This segment's growth in the global market is being driven by a growing patient pool and reimbursement policies in most industrialised countries.
The home care setting is more popular because patients can receive continuous care from home by reading self-management manuals, occasional visits by nurse, using telemedicine, communicating via phone, and accepting follow-ups for doctors.
The leading players active within this space are focussing on developing products with advanced technology to suit wide variety of population. Additionally, they are highly active in raising funds to expand their customer pool in new regions.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the stoma/ostomy care market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa. |
| Key Market Segments Covered | Product, Surgery, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global stoma/ostomy care sector is worth US$ 3.8 Billion in 2022 and is set to expand 1.5X over the next ten years.
The global market is expected to reach a valuation of US$ 4.0 Billion by the end of 2023.
Stoma/ostomy care market is expected to reach US$ 6.5 Billion by the end of 2033, with sales revenue expected to register 4.9% CAGR over the forecast duration.
The global market expanded at a CAGR of about 5.0% over the last 5 years between 2017 and 2022.
The global market is projected to expand at a CAGR of around 4.9% between 2023 and 2033.
The USA, China, Germany, Russia, and Indonesia are expected to drive demand for stoma/ostomy care products.
Coloplast Corp, BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc., 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc., Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG, Salts Healthcare Ltd., Securi–T USA, Welland Medical Limited and Flexicare Group Limited are some of the key players active in this space.
Ostomy Bags is expected to hold a significant revenue share of 84.3% in the global market by 2023.
The USA market will hold the market share of around 28.7% in 2023 global market.
The market is valued at US$ 4 billion in 2023.
The market captured a CAGR of 5% from 2017 to 2022.
The market is predicted to reach US$ 6.5 billion in 2033.
The market is projected to expand at a 4.9% CAGR through 2033.
ConvaTec Inc., Hollister Inc., and, EuroMed, Inc. are the leading market players.
1. Executive Summary | Stoma/Ostomy Care Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption/Usage Analysis
4.2. Key Promotional Strategies, by Manufacturers
4.3. Key Regulations
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Disease Epidemiology
4.7. Reimbursement Scenario
4.8. Value Chain Analysis
5. Market Background
5.1. Macro–Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Gastrointestinal Devices Market Overview
5.2. Forecast Factors – Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. New Product Launches and Approvals
5.2.3. Rising Awareness of Health and Wellness Factor
5.2.4. R&D Expenditure by Key Players
5.2.5. Rising Consumer Awareness of the Product
5.2.6. Rising Adoption of Ostomy Care Products
5.2.7. Increase Adoption of for Various Applications
5.2.8. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID–19 Crisis Analysis
6.1. COVID–19 and Impact Analysis
6.1.1. By Surgery Type
6.1.2. By Product
6.1.3. By Application
6.1.4. By End User
6.1.5. By Country
6.2. 2022 Market Scenario
7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2017 to 2022
7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
7.2.1.1. Y–o–Y Growth Trend Analysis
8. Global Market – Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break–up
8.2.1.1. Manufacturer Level Pricing
8.2.1.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, 2023 to 2033
9.2.1. Y–o–Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Surgery Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Surgery Type, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Surgery Type, 2023 to 2033
10.3.1. Colostomy
10.3.2. Ileostomy
10.3.3. Urostomy
10.4. Market Attractiveness Analysis by Surgery Type
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033
11.3.1. Ostomy Bags/Pouches
11.3.2. Ostomy Accessories
11.3.2.1. Belts & Tapes
11.3.2.2. Skin Protection &Skin Barrier
11.3.2.3. Irrigation Sets
11.3.2.4. Convex Inserts
11.3.2.5. Stoma Caps
11.4. Market Attractiveness Analysis by Product
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
12.3.1. Cancer
12.3.2. Inflammatory Bowel Disease
12.3.3. Bowel Obstruction
12.3.4. Fecal Incontinence
12.3.5. Trauma & Infection
12.4. Market Attractiveness Analysis by Application
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
13.3.1.1. 12.3.1. Hospital and Specialty Clinics
13.3.2. Home Care Settings
13.3.3. Ambulatory Surgical Centers
13.4. Market Attractiveness Analysis by Application
14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
14.3.1.1. 13.3.1 North America
14.3.1.2. 13.3.2 Latin America
14.3.1.3. 13.3.3 Europe
14.3.1.4. 13.3.4 East Asia
14.3.1.5. 13.3.5 South Asia
14.3.1.6. 13.3.6 Oceania
14.3.1.7. 13.3.7 Middle East and Africa
14.4. Market Attractiveness Analysis by Region
15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. USA
15.3.1.2. Canada
15.3.2. By Surgery Type
15.3.3. By Product
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Surgery Type
15.4.3. By Product
15.4.4. By Application
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. USA Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Surgery Type
15.8.1.2.2. By Product
15.8.1.2.3. By Application
15.8.1.2.4. By End User
15.8.2. Canada Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Surgery Type
15.8.2.2.2. By Product
15.8.2.2.3. By Application
15.8.2.2.4. By End User
16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Mexico
16.3.1.2. Brazil
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Surgery Type
16.3.3. By Product
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Surgery Type
16.4.3. By Product
16.4.4. By Application
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Mexico Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Surgery Type
16.8.1.2.2. By Product
16.8.1.2.3. By Application
16.8.1.2.4. By End User
16.8.2. Brazil Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Surgery Type
16.8.2.2.2. By Product
16.8.2.2.3. By Application
16.8.2.2.4. By End User
16.8.3. Argentina Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Surgery Type
16.8.3.2.2. By Product
16.8.3.2.3. By Application
16.8.3.2.4. By End User
17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4.United kingdom
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Surgery Type
17.3.3. By Product
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Surgery Type
17.4.3. By Product
17.4.4. By Application
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Germany Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Surgery Type
17.8.1.2.2. By Product
17.8.1.2.3. By Application
17.8.1.2.4. By End User
17.8.2. Italy Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Surgery Type
17.8.2.2.2. By Product
17.8.2.2.3. By Application
17.8.2.2.4. By End User
17.8.3. France Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Surgery Type
17.8.3.2.2. By Product
17.8.3.2.3. By Application
17.8.3.2.4. By End User
17.8.4.United kingdom Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Surgery Type
17.8.4.2.2. By Product
17.8.4.2.3. By Application
17.8.4.2.4. By End User
17.8.5. Spain Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Surgery Type
17.8.5.2.2. By Product
17.8.5.2.3. By Application
17.8.5.2.4. By End User
17.8.6. BENELUX Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Surgery Type
17.8.6.2.2. By Product
17.8.6.2.3. By Application
17.8.6.2.4. By End User
17.8.7. Russia Market Analysis
17.8.7.1. Introduction
17.8.7.2. Market Analysis and Forecast by Market Taxonomy
17.8.7.2.1. By Surgery Type
17.8.7.2.2. By Product
17.8.7.2.3. By Application
17.8.7.2.4. By End User
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Surgery Type
18.3.3. By Product
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Surgery Type
18.4.3. By Product
18.4.4. By Application
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints – Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. China Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Surgery Type
18.8.1.2.2. By Product
18.8.1.2.3. By Application
18.8.1.2.4. By End User
18.8.2. Japan Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Surgery Type
18.8.2.2.2. By Product
18.8.2.2.3. By Application
18.8.2.2.4. By End User
18.8.3. South Korea Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Surgery Type
18.8.3.2.2. By Product
18.8.3.2.3. By Application
18.8.3.2.4. By End User
19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Malaysia
19.3.1.4. Thailand
19.3.1.5. Rest of South Asia
19.3.2. By Surgery Type
19.3.3. By Product
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Surgery Type
19.4.3. By Product
19.4.4. By Application
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints – Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. India Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Surgery Type
19.8.1.2.2. By Product
19.8.1.2.3. By Application
19.8.1.2.4. By End User
19.8.2. Indonesia Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Surgery Type
19.8.2.2.2. By Product
19.8.2.2.3. By Application
19.8.2.2.4. By End User
19.8.3. Malaysia Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Surgery Type
19.8.3.2.2. By Product
19.8.3.2.3. By Application
19.8.3.2.4. By End User
19.8.4. Thailand Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Surgery Type
19.8.4.2.2. By Product
19.8.4.2.3. By Application
19.8.4.2.4. By End User
20. Oceania Market 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Surgery Type
20.3.3. By Product
20.3.4. By Application
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Surgery Type
20.4.3. By Product
20.4.4. By Application
20.4.5. By End User
20.5. Market Trends
20.6. Key Market Participants – Intensity Mapping
20.7. Drivers and Restraints – Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. Australia Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Surgery Type
20.8.1.2.2. By Product
20.8.1.2.3. By Application
20.8.1.2.4. By End User
20.8.2. New Zealand Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Surgery Type
20.8.2.2.2. By Product
20.8.2.2.3. By Application
20.8.2.2.4. By End User
21. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022
21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Türkiye
21.3.1.3. North Africa
21.3.1.4. South Africa
21.3.1.5. Rest of Middle East and Africa
21.3.2. By Surgery Type
21.3.3. By Product
21.3.4. By Application
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Surgery Type
21.4.3. By Product
21.4.4. By Application
21.4.5. By End User
21.5. Market Trends
21.6. Key Market Participants – Intensity Mapping
21.7. Drivers and Restraints – Impact Analysis
21.8. Country Level Analysis & Forecast
21.8.1. GCC Countries Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Surgery Type
21.8.1.2.2. By Product
21.8.1.2.3. By Application
21.8.1.2.4. By End User
21.8.2. Türkiye Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Surgery Type
21.8.2.2.2. By Product
21.8.2.2.3. By Application
21.8.2.2.4. By End User
21.8.3. South Africa Market Analysis
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast by Market Taxonomy
21.8.3.2.1. By Surgery Type
21.8.3.2.2. By Product
21.8.3.2.3. By Application
21.8.3.2.4. By End User
21.8.4. North Africa Market Analysis
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast by Market Taxonomy
21.8.4.2.1. By Surgery Type
21.8.4.2.2. By Product
21.8.4.2.3. By Application
21.8.4.2.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Coloplast Corp
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Sales Footprint
23.3.1.4. Key Financials
23.3.1.5. SWOT Analysis
23.3.1.6. Key Developments
23.3.1.7. Strategy Overview
23.3.1.7.1. Marketing Strategy
23.3.1.7.2. Product Strategy
23.3.1.7.3. Channel Strategy
23.3.2. BAE Systems Plc
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Sales Footprint
23.3.2.4. Key Financials
23.3.2.5. SWOT Analysis
23.3.2.6. Key Developments
23.3.2.7. Strategy Overview
23.3.2.7.1. Marketing Strategy
23.3.2.7.2. Product Strategy
23.3.2.7.3. Channel Strategy
23.3.3. ConvaTec Inc.
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Sales Footprint
23.3.3.4. Key Financials
23.3.3.5. SWOT Analysis
23.3.3.6. Key Developments
23.3.3.7. Strategy Overview
23.3.3.7.1. Marketing Strategy
23.3.3.7.2. Product Strategy
23.3.3.7.3. Channel Strategy
23.3.4. Hollister Inc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Sales Footprint
23.3.4.4. Key Financials
23.3.4.5. SWOT Analysis
23.3.4.6. Key Developments
23.3.4.7. Strategy Overview
23.3.4.7.1. Marketing Strategy
23.3.4.7.2. Product Strategy
23.3.4.7.3. Channel Strategy
23.3.5. EuroMed, Inc
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Sales Footprint
23.3.5.4. Key Financials
23.3.5.5. SWOT Analysis
23.3.5.6. Key Developments
23.3.5.7. Strategy Overview
23.3.5.7.1. Marketing Strategy
23.3.5.7.2. Product Strategy
23.3.5.7.3. Channel Strategy
23.3.6. 3M Company
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Sales Footprint
23.3.6.4. Key Financials
23.3.6.5. SWOT Analysis
23.3.6.6. Key Developments
23.3.6.7. Strategy Overview
23.3.6.7.1. Marketing Strategy
23.3.6.7.2. Product Strategy
23.3.6.7.3. Channel Strategy
23.3.7. Smith & Nephew plc
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Sales Footprint
23.3.7.4. Key Financials
23.3.7.5. SWOT Analysis
23.3.7.6. Key Developments
23.3.7.7. Strategy Overview
23.3.7.7.1. Marketing Strategy
23.3.7.7.2. Product Strategy
23.3.7.7.3. Channel Strategy
23.3.8. FNC Medical
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Sales Footprint
23.3.8.4. Key Financials
23.3.8.5. SWOT Analysis
23.3.8.6. Key Developments
23.3.8.7. Strategy Overview
23.3.8.7.1. Marketing Strategy
23.3.8.7.2. Product Strategy
23.3.8.7.3. Channel Strategy
23.3.9. Nu-Hope Laboratories, Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Sales Footprint
23.3.9.4. Key Financials
23.3.9.5. SWOT Analysis
23.3.9.6. Key Developments
23.3.9.7. Strategy Overview
23.3.9.7.1. Marketing Strategy
23.3.9.7.2. Product Strategy
23.3.9.7.3. Channel Strategy
23.3.10. Marlen Manufacturing & Development Co.
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Sales Footprint
23.3.10.4. Key Financials
23.3.10.5. SWOT Analysis
23.3.10.6. Key Developments
23.3.10.7. Strategy Overview
23.3.10.7.1. Marketing Strategy
23.3.10.7.2. Product Strategy
23.3.10.7.3. Channel Strategy
23.3.11. Torbot Group, Inc
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Sales Footprint
23.3.11.4. Key Financials
23.3.11.5. SWOT Analysis
23.3.11.6. Key Developments
23.3.11.7. Strategy Overview
23.3.11.7.1. Marketing Strategy
23.3.11.7.2. Product Strategy
23.3.11.7.3. Channel StrategY
23.3.12. Cymed Micro Skin
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Sales Footprint
23.3.12.4. Key Financials
23.3.12.5. SWOT Analysis
23.3.12.6. Key Developments
23.3.12.7. Strategy Overview
23.3.12.7.1. Marketing Strategy
23.3.12.7.2. Product Strategy
23.3.12.7.3. Channel Strategy
23.3.13. Alcare Co., Ltd.
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Sales Footprint
23.3.13.4. Key Financials
23.3.13.5. SWOT Analysis
23.3.13.6. Key Developments
23.3.13.7. Strategy Overview
23.3.13.7.1. Marketing Strategy
23.3.13.7.2. Product Strategy
23.3.13.7.3. Channel Strategy
23.3.14. B. Braun Melsungen AG.
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Sales Footprint
23.3.14.4. Key Financials
23.3.14.5. SWOT Analysis
23.3.14.6. Key Developments
23.3.14.7. Strategy Overview
23.3.14.7.1. Marketing Strategy
23.3.14.7.2. Product Strategy
23.3.14.7.3. Channel Strategy
23.3.15. Salts Healthcare Ltd
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Sales Footprint
23.3.15.4. Key Financials
23.3.15.5. SWOT Analysis
23.3.15.6. Key Developments
23.3.15.7. Strategy Overview
23.3.15.7.1. Marketing Strategy
23.3.15.7.2. Product Strategy
23.3.15.7.3. Channel Strategy
23.3.16. Securi-T USA.
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Sales Footprint
23.3.16.4. Key Financials
23.3.16.5. SWOT Analysis
23.3.16.6. Key Developments
23.3.16.7. Strategy Overview
23.3.16.7.1. Marketing Strategy
23.3.16.7.2. Product Strategy
23.3.16.7.3. Channel Strategy
23.3.17. Welland Medical Limited
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Sales Footprint
23.3.17.4. Key Financials
23.3.17.5. SWOT Analysis
23.3.17.6. Key Developments
23.3.17.7. Strategy Overview
23.3.17.7.1. Marketing Strategy
23.3.17.7.2. Product Strategy
23.3.17.7.3. Channel Strategy
23.3.18. Flexicare Group Limited
23.3.18.1. Overview
23.3.18.2. Product Portfolio
23.3.18.3. Sales Footprint
23.3.18.4. Key Financials
23.3.18.5. SWOT Analysis
23.3.18.6. Key Developments
23.3.18.7. Strategy Overview
23.3.18.7.1. Marketing Strategy
23.3.18.7.2. Product Strategy
23.3.18.7.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Explore Healthcare Insights
View Reports
Stoma/Ostomy Care Market
